Surgical errors, from operating on the wrong part of the body to giving a patient the wrong organ, are rare. In fact, they happen in only .03 percent of all operations in the U.S. Still, up to 10,000 patients are injured every year from such surgical "never events." Florida residents will want to know about a startup in Chicago that may have the solution for not only reducing surgical errors but also eliminating them for good.
Prior to 1846, all surgeries were performed on patients who were alert and unmedicated. Thankfully, those days are over.
Many Florida patients have had a number of X-rays over the course of their lives. The revolutionary technology, which was developed at the end of the 19th century, has been critical to understanding the inside of the human body and viewing problems. Most X-ray devices currently in use work in similar ways; rays are beamed through the object being inspected onto a rigid detector that can absorb the rays and produce the internal image of the object or person.
One cause of early childhood seizures for affected kids in Florida was uncovered in a study by the University of Utah Health. Early infantile epileptic encephalopathy (EIEE) begins in the first months of life with seizures that medication is unable to stop. While uncommon, the condition still occurs in around 1.2 out of every 1,000 live births in the United States. Children born with EIEE experience intellectual disabilities, developmental delays and, often, early death.
As a general rule, medical professionals do a good job whenever a Florida patient sees them. However, they may not be at peak performance in the afternoon. This is partially because they fall victim to the energy slump that many people experience just after lunch. Circadian lows in the afternoon could also lead to more mistakes during a surgery, according to research from Duke University.
Many Florida women have breast cancer, and it accounts for roughly 25 percent of all cancer cases around the world. Survival rates are comparatively high, thanks to advances in the detection of breast cancer tumors, but some tumors are more subtle and thus at a higher risk for proving fatal. This is where the European-funded project MAMMA comes in.